2010 Press Releases

Receive E-mail Alerts

|

RSS Feeds

Keyword Search

2010 | 2009 | 2008 | 2007 | 2006

Date Title   09/01/10 Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine 08/24/10 Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars 08/24/10 Emergent BioSolutions Announces Appointment of John E. Niederhuber, M.D. to the Company's Board of Directors 08/12/10 Emergent BioSolutions to Acquire Trubion Pharmaceuticals 08/11/10 Emergent BioSolutions and Temasek Life Sciences Ventures Establish Joint Venture to Develop Broad Spectrum Pandemic Flu Vaccine and Therapeutic 08/05/10 Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2010 07/20/10 Emergent Revises Upward 2010 Financial Forecast 07/16/10 Maryland Governor Martin O'Malley Leads Ribbon Cutting Ceremony at Emergent's Baltimore Manufacturing Facility 07/14/10 Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax 07/13/10 Emergent BioSolutions to Release Second Quarter 2010 Financial Results and Conduct a Conference Call on August 5, 2010 07/12/10 Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians 06/24/10 Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments 06/04/10 Emergent BioSolutions Announces Appointment of Marvin White to the Company's Board of Directors 06/01/10 Emergent BioSolutions to Participate in June 2010 Investor Conferences 05/19/10 Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 20, 2010 at 10:00 am Eastern; Webcast Will Be Available 05/17/10 Emergent BioSolutions IND for Anthrax Monoclonal Antibody Therapeutic Clears FDA Review 05/13/10 Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland 05/06/10 Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly 05/05/10 Emergent BioSolutions Reports Financial Results for First Quarter 2010 05/03/10 Emergent BioSolutions to Participate on Vaccine Panel at BIO International Convention 2010 04/21/10 Emergent BioSolutions to Release First Quarter 2010 Financial Results and Conduct a Conference Call on May 5, 2010 03/11/10 Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader 03/04/10 Emergent BioSolutions Reports Financial Results for Full Year 2009 02/22/10 Emergent BioSolutions to Participate in March 2010 Investor Conferences 01/25/10 Emergent BioSolutions to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 4, 2010 01/11/10 Emergent BioSolutions Announces R. Don Elsey, Chief Financial Officer, to Join Board of Directors of MdBio Foundation 01/11/10 Emergent BioSolutions Provides Preliminary 2009 Financial Results and Guidance for 2010